FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
Open accessThe DOI matches its Crossref record; 107 of the 109 references it cites were found in a registry or an index.
Abstract
The purpose of these guidelines is to assist physicians in recommending, performing, interpreting and reporting the results of FDG PET/CT for oncological imaging of adult patients. PET is a quantitative imaging technique and therefore requires a common quality control (QC)/quality assurance (QA) procedure to maintain the accuracy and precision of quantitation. Repeatability and reproducibility are two essential requirements for any quantitative measurement and/or imaging biomarker. Repeatability relates to the uncertainty in obtaining the same result in the same patient when he or she is examined more than once on the same system. However, imaging biomarkers should also have adequate reproducibility, i.e. the ability to yield the same result in the same patient when that patient is examined on different systems and at different imaging sites. Adequate repeatability and reproducibility are essential for the clinical management of patients and the use of FDG PET/CT within multicentre trials. A common standardised imaging procedure will help promote the appropriate use of FDG PET/CT imaging and increase the value of publications and, therefore, their contribution to evidence-based medicine. Moreover, consistency in numerical values between platforms and institutes that acquire the data will potentially enhance the role of semiquantitative and quantitative image interpretation. Precision and accuracy are additionally important as FDG PET/CT is used to evaluate tumour response as well as for diagnosis, prognosis and staging. Therefore both the previous and these new guidelines specifically aim to achieve standardised uptake value harmonisation in multicentre settings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The European and American guidelines for PET/CT imaging recommended the measurement of blood glucose level prior to scanning and rescheduling the examination whenever the level exceeds 200 mg/dL.[5,6]”
From Intrapatient variability of 18F-FDG uptake in normal tissues (2022) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although all these errors are potentially severe, it should be noted that they can easily be avoided by following existing guidelines published by the EANM [24] or the EANM Research Ltd. (EARL) initiative [67].”
From Influences on PET Quantification and Interpretation (2022) · cites this paper as [24]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interpretation of PET images in routine clinical practice primarily follows visual criteria, i.e., the assessment of generalized or focal pathologies in tracer accumulation, while quantitative parameters, including SUV, provide orientation or additional information at most [24].”
From Influences on PET Quantification and Interpretation (2022) · cites this paper as [24]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“European Association of Nuclear Medicine (EANM) [40] guidelines suggest if the plasma glucose level is higher than or equal to 200 mg/dl, the FDG PET/CT study should be rescheduled.”
From Effect of blood glucose level on standardized uptake value (SUV) in 18F-FDG PET-scan: a systematic review and meta-analysis of 20,807 individual SUV measurements (2019) · cites this paper as [40]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Current available PET-scan preparation protocols suggest rescheduling the scan or consideration of rapid-acting insulin injection prior to PET scan or scan rescheduling in patients with hyperglycemia ranging from 120 mg/dl to 200 mg/dl, and recommend inconsistent and diverse cut-offs for insulin injection or scan rescheduling [39,40].”
From Effect of blood glucose level on standardized uptake value (SUV) in 18F-FDG PET-scan: a systematic review and meta-analysis of 20,807 individual SUV measurements (2019) · cites this paper as [40]
Experimental — accuracy not yet measured
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
Wahl, R. L., Jacene, H., Kasamon, Y., & Lodge, M. A. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.057307 · Cited by 3,777 · cited 8×
“2-cm diameter (or 1-mL volume) spherical VOI [61] positioned such that the average value across all positions within the lesion is maximized.”
InfluentialUniversity of California, San Francisco
(1974) · Medical History · doi:10.1017/s0025727300019682 · Cited by 2,222
Young, H., Baum, R., Cremerius, U., Herholz, K., Hoekstra, O., Lammertsma, A. A., Pruim, J., & Price, P. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00229-4 · Cited by 1,720
Self-citationBarrington, S. F., Mikhaeel, N. G., Kostakoglu, L., Meignan, M., Hutchings, M., Müeller, S. P., Schwartz, L. H., Zucca, E., Fisher, R. I., Trotman, J., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.5229 · Cited by 1,665 · cited 1×
“Further, a fivepoint scale has been proposed for assessment of lymphoma therapy response [80].”
Self-citationJuweid, M. E., Stroobants, S., Hoekstra, O. S., Mottaghy, F. M., Dietlein, M., Guermazi, A., Wiseman, G. A., Kostakoglu, L., Scheidhauer, K., Buck, A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.2305 · Cited by 1,335 · cited 2×
“Some criteria have already been proposed [78, 79].”
Self-citationFDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0
Boellaard, R., O’Doherty, M. J., Weber, W. A., Mottaghy, F. M., Lonsdale, M. N., Stroobants, S. G., Oyen, W. J. G., Kotzerke, J., Hoekstra, O. S., Pruim, J., et al. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1297-4 · Cited by 1,326 · cited 6×
“• The effects of growth factors (G-CSF and GM-CSF) on FDG biodistribution (due to enhanced bone marrow uptake) generally last for more than 2 weeks after the final administration [20].”
InfluentialSelf-citationRecommendations on the Use of 18F-FDG PET in Oncology
Fletcher, J. W., Djulbegovic, B., Soares, H. P., Siegel, B. A., Lowe, V. J., Lyman, G. H., Coleman, R. E., Wahl, R., Paschold, J. C., Avril, N., et al. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.047787 · Cited by 1,101
Self-citationStandards for PET Image Acquisition and Quantitative Data Analysis
Boellaard, R. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.057182 · Cited by 902 · cited 4×
“This requires reconstruction settings to be chosen such as to achieve matching convergence and spatial resolution across various systems and sites, especially within a multicentre setting [48, 58, 59].”
InfluentialSelf-citationQuantification of Lean Bodyweight
Janmahasatian, S., Duffull, S. B., Ash, S., Ward, L. C., Byrne, N. M., & Green, B. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544100-00004 · Cited by 900 · cited 1×
“[62]: LBM = 9,270 × weight/(6,680 + 216 × BMI) LBM = 9,270 × weight/(8,780 + 244 × BMI) where LBM and LBM are the LBM for males and females, and BMI is body mass index (weight/height), and weight and height are in kilograms and centimetres, respectively.”
Shankar, L. K., Hoffman, J. M., Bacharach, S. L., Graham, M. M., Karp, J. S., Lammertsma, A. A., Larson, S. M., Mankoff, D. A., Siegel, B. A., den Abbeele, A. V., et al. (2006) · PubMed · Cited by 765
Self-citation
Research works printed but not linked: 1
- 77. Padhani AR. Imaging in the evaluation of cancer. In: Nicholson T, editor. Recommendations for cross-sectional imaging in cancer management. 2nd ed. London: The Royal College of Radiologists; 2014.
Cited by
Zwanenburg, A., Vallières, M., Abdalah, M. A., Aerts, H. J. W. L., Andrearczyk, V., Apte, A., Ashrafinia, S., Bakas, S., Beukinga, R. J., Boellaard, R., et al. (2020) · Radiology · doi:10.1148/radiol.2020191145 · Cited by 4,177
Self-citationApplications and limitations of radiomics
Yip, S. S. F., & Aerts, H. J. W. L. (2016) · Physics in Medicine and Biology · doi:10.1088/0031-9155/61/13/r150 · Cited by 1,210
Imaging biomarker roadmap for cancer studies
O'Connor, J. P. B., Aboagye, E. O., Adams, J. E., Aerts, H. J. W. L., Barrington, S. F., Beer, A. J., Boellaard, R., Bohndiek, S. E., Brady, M., Brown, G., et al. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.162 · Cited by 1,091
“ADC, the family of K and related perfusion biomarkers derived from either CT or MRI and (18)F-fluorothymidine PET) continue to be measured and analysed in disparate ways by different laboratories using a wide range of software systems, despite attempts to standardise and harmonise these methods (2, 3, 11-14).”
Self-citationLactate: the ugly duckling of energy metabolism
Rabinowitz, J. D., & Enerbäck, S. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0243-4 · Cited by 1,049
Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)
Zhou, J., Sun, H., Wang, Z., Cong, W., Wang, J., Zeng, M., Zhou, W., Bie, P., Liu, L., Wen, T., et al. (2020) · Liver Cancer · doi:10.1159/000509424 · Cited by 800
68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0
Fendler, W. P., Eiber, M., Beheshti, M., Bomanji, J., Ceci, F., Cho, S., Giesel, F., Haberkorn, U., Hope, T. A., Kopka, K., et al. (2017) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3670-z · Cited by 750
Self-citationGuidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition)
Zhou, J., Sun, H.-C., Wang, Z., Cong, W.-M., Wang, J.-H., Zeng, M.-S., Yang, J.-M., Bie, P., Liu, L.-X., Wen, T.-F., et al. (2018) · Liver Cancer · doi:10.1159/000488035 · Cited by 649
Chakfé, N., Diener, H., Lejay, A., Assadian, O., Berard, X., Caillon, J., Fourneau, I., Glaudemans, A. W. J. M., Koncar, I., Lindholt, J., et al. (2020) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2019.10.016 · Cited by 563
Law, I., Albert, N. L., Arbizu, J., Boellaard, R., Drzezga, A., Galldiks, N., la Fougère, C., Langen, K.-J., Lopci, E., Lowe, V., et al. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4207-9 · Cited by 556
Self-citationWriting group, Slart, R. H. J. A., Reviewer group, Cardiovascular, M. O. E., Inflammation, M. O. E. I. &., Members of Committees, S. C., Members of Council, P. I. G., Members of, A. S. N. C., & EANM Committee Coordinator (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-3973-8 · Cited by 503
“The contrast material dose depends on the patient's body weight, body mass index, and kidney function (recent estimated glomerular filtration rate) [26].”
BackgroundMethodInfluentialSundin, A., Arnold, R., Baudin, E., Cwikla, J. B., Eriksson, B., Fanti, S., Fazio, N., Giammarile, F., Hicks, R. J., Kjaer, A., et al. (2017) · Neuroendocrinology · doi:10.1159/000471879 · Cited by 501
Self-citationPerformance Characteristics of the Digital Biograph Vision PET/CT System
van Sluis, J., de Jong, J., Schaar, J., Noordzij, W., van Snick, P., Dierckx, R., Borra, R., Willemsen, A., & Boellaard, R. (2019) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.215418 · Cited by 484
“The default whole-body reconstruction protocol may result in voxels smaller than 3 mm in any direction (especially slice thickness), which is noncompliant with current EARL criteria (19,20).”
BackgroundMethodSelf-citationPSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0
Fendler, W. P., Eiber, M., Beheshti, M., Bomanji, J., Calais, J., Ceci, F., Cho, S. Y., Fanti, S., Giesel, F. L., Goffin, K., et al. (2023) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-022-06089-w · Cited by 410
Self-citationVercellino, L., Di Blasi, R., Kanoun, S., Tessoulin, B., Rossi, C., D'Aveni-Piney, M., Obéric, L., Bodet-Milin, C., Bories, P., Olivier, P., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020003001 · Cited by 410
“Method for TMTV measurement TMTV was computed with the 41% maximum standardized uptake value threshold method, as recommended by the European Association of Nuclear Medicine and published for various lymphoma subtypes.(16) TMTV was measured by each center, as previously described(9,11); briefly, using the free semiaut…”
MethodTaïeb, D., Hicks, R. J., Hindié, E., Guillet, B. A., Avram, A., Ghedini, P., Timmers, H. J., Scott, A. T., Elojeimy, S., Rubello, D., et al. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04398-1 · Cited by 403
“In Europe, national guidelines may apply [135].”
BackgroundA Postreconstruction Harmonization Method for Multicenter Radiomic Studies in PET
Orlhac, F., Boughdad, S., Philippe, C., Stalla-Bourdillon, H., Nioche, C., Champion, L., Soussan, M., Frouin, F., Frouin, V., & Buvat, I. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.199935 · Cited by 393
Verberne, H. J., Acampa, W., Anagnostopoulos, C., Ballinger, J., Bengel, F., De Bondt, P., Buechel, R. R., Cuocolo, A., van Eck-Smit, B. L. F., Flotats, A., et al. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3139-x · Cited by 366
Larue, R. T. H. M., Defraene, G., De Ruysscher, D., Lambin, P., & van Elmpt, W. (2017) · The British Journal of Radiology · doi:10.1259/bjr.20160665 · Cited by 363
Gebhart, G., Lamberts, L. E., Wimana, Z., Garcia, C., Emonts, P., Ameye, L., Stroobants, S., Huizing, M., Aftimos, P., Tol, J., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdv577 · Cited by 355
“FDG–PET/CT procedures described in supplementary Appendix, available at Annals of Oncology online, were based on European Association of Nuclear Medicine (EANM) recommendations [15].”
MethodSelf-citationA Guide to ComBat Harmonization of Imaging Biomarkers in Multicenter Studies
Orlhac, F., Eertink, J. J., Cottereau, A.-S., Zijlstra, J. M., Thieblemont, C., Meignan, M., Boellaard, R., & Buvat, I. (2022) · Journal of Nuclear Medicine · doi:10.2967/jnumed.121.262464 · Cited by 348
“Much effort has been deployed in recent years to propose procedures to harmonize image quality (6), including the successful European Association of Nuclear Medicine Research Ltd. (EARL) accreditation program (7,8).”
BackgroundInfluentialSelf-citationAide, N., Lasnon, C., Veit-Haibach, P., Sera, T., Sattler, B., & Boellaard, R. (2017) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3740-2 · Cited by 344
“MATV can be obtained by delineating the tumor using, for example, a 41% of SUVmax isocontour threshold as per EANM guidelines [4, 5], or by advanced algorithms including information on gradients or the background surrounding the tumor.”
MethodSelf-citationAdvances in PET imaging of cancer
Schwenck, J., Sonanini, D., Cotton, J. M., Rammensee, H.-G., la Fougère, C., Zender, L., & Pichler, B. J. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-023-00576-4 · Cited by 312
Chen, K. Y., Cypess, A. M., Laughlin, M. R., Haft, C. R., Hu, H. H., Bredella, M. A., Enerbäck, S., Kinahan, P. E., Lichtenbelt, W. V. M., Lin, F. I., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.07.014 · Cited by 308
Zwanenburg, A. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04391-8 · Cited by 306
van Velden, F. H. P., Kramer, G. M., Frings, V., Nissen, I. A., Mulder, E. R., de Langen, A. J., Hoekstra, O. S., Smit, E. F., & Boellaard, R. (2016) · Molecular Imaging and Biology · doi:10.1007/s11307-016-0940-2 · Cited by 286
Self-citationAlberts, I., Hünermund, J.-N., Prenosil, G., Mingels, C., Bohn, K. P., Viscione, M., Sari, H., Vollnberg, B., Shi, K., Afshar-Oromieh, A., et al. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05282-7 · Cited by 286
“The background was measured by the placement of a 14 cm(3) volume-of-interest (VOI) in healthy liver tissue in the right liver lobe as previously described [17].”
MethodFDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas
Barrington, S. F., & Kluge, R. (2017) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3690-8 · Cited by 281
“In response evaluation, this effect may compromise both the visual Deauville scoring and the quantitative tumour-to-reference organ SUV ratios [74, 75], For response classification, it is therefore important to use standardized reconstruction methods as defined in the EANM procedure guideline for tumour imaging, espec…”
MethodSelf-citationA whole-body FDG-PET/CT Dataset with manually annotated Tumor Lesions
Gatidis, S., Hepp, T., Früh, M., La Fougère, C., Nikolaou, K., Pfannenberg, C., Schölkopf, B., Küstner, T., Cyran, C., & Rubin, D. (2022) · Scientific Data · doi:10.1038/s41597-022-01718-3 · Cited by 257
Co-Learning Feature Fusion Maps From PET-CT Images of Lung Cancer
Kumar, A., Fulham, M., Feng, D., & Kim, J. (2020) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2019.2923601 · Cited by 238
“Similarly, some areas of high FDG uptake on PET images may be linked to normal physiological uptake, such as in the heart, and these regions need to be filtered out based upon knowledge about anatomical characteristics from CT to differentiate them from abnormal PET regions [23]– [26].”
Backgroundon behalf of the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM), Bucerius, J., Hyafil, F., Verberne, H. J., Slart, R. H. J. A., Lindner, O., Sciagra, R., Agostini, D., Übleis, C., Gimelli, A., et al. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3259-3 · Cited by 257
Nielsen, B. D., Gormsen, L. C., Hansen, I. T., Keller, K. K., Therkildsen, P., & Hauge, E.-M. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4021-4 · Cited by 243
Texture Analysis of Imaging: What Radiologists Need to Know
Varghese, B. A., Cen, S. Y., Hwang, D. H., & Duddalwar, V. A. (2019) · American Journal of Roentgenology · doi:10.2214/ajr.18.20624 · Cited by 243
Studies of a Next-Generation Silicon-Photomultiplier–Based Time-of-Flight PET/CT System
Hsu, D. F. C., Ilan, E., Peterson, W. T., Uribe, J., Lubberink, M., & Levin, C. S. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.189514 · Cited by 241
Willmann, J. K., Bonomo, L., Testa, A. C., Rinaldi, P., Rindi, G., Valluru, K. S., Petrone, G., Martini, M., Lutz, A. M., & Gambhir, S. S. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.70.8594 · Cited by 235
Andersson, M., Johansson, L., Eckerman, K., & Mattsson, S. (2017) · EJNMMI Research · doi:10.1186/s13550-017-0339-3 · Cited by 230
“5 min per bed position [35] for a patient weighing 73 kg, the absorbed dose was calculated for 290 MBq of administered activity.”
Limitations and Pitfalls of FDG-PET/CT in Infection and Inflammation
Pijl, J. P., Nienhuis, P. H., Kwee, T. C., Glaudemans, A. W. J. M., Slart, R. H. J. A., & Gormsen, L. C. (2021) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2021.06.008 · Cited by 229
Papadimitroulas, P., Brocki, L., Christopher Chung, N., Marchadour, W., Vermet, F., Gaubert, L., Eleftheriadis, V., Plachouris, D., Visvikis, D., Kagadis, G. C., et al. (2021) · Physica Medica · doi:10.1016/j.ejmp.2021.03.009 · Cited by 226
“One recent study evaluated the performance of existing standardization guidelines for PET/CT imaging (i.e., EARL (European Association of Nuclear Medicine (EANM) Research Ltd. [135]) to reduce the variability of radiomic features across different scanner models and reconstruction settings [137].”
Mali, S. A., Ibrahim, A., Woodruff, H. C., Andrearczyk, V., Müller, H., Primakov, S., Salahuddin, Z., Chatterjee, A., & Lambin, P. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11090842 · Cited by 207
“For standardization of PET imaging, the European Association of Nuclear Medicine (EANM) [45] launched the EARL (EANM Research Ltd.) program covering areas such as scan acquisition, processing of images, and image interpretation.”
MethodHow can we combat multicenter variability in MR radiomics? Validation of a correction procedure
Orlhac, F., Lecler, A., Savatovski, J., Goya-Outi, J., Nioche, C., Charbonneau, F., Ayache, N., Frouin, F., Duron, L., & Buvat, I. (2021) · European Radiology · doi:10.1007/s00330-020-07284-9 · Cited by 210
“In prospective studies, imaging protocols could be harmonized upstream between centers to minimize the impact of imaging protocols on feature values [5, 6], although harmonizing between machines of different generations often comes with degrading the image quality achieved by the most recent scanners [5].”
Background68Ga-PSMA ligand PET/CT in patients with prostate cancer: How we review and report
Rauscher, I., Maurer, T., Fendler, W. P., Sommer, W. H., Schwaiger, M., & Eiber, M. (2016) · Cancer Imaging · doi:10.1186/s40644-016-0072-6 · Cited by 208
“[31].”
Quantification, improvement, and harmonization of small lesion detection with state-of-the-art PET
van der Vos, C. S., Koopman, D., Rijnsdorp, S., Arends, A. J., Boellaard, R., van Dalen, J. A., Lubberink, M., Willemsen, A. T. M., & Visser, E. P. (2017) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3727-z · Cited by 206
Self-citationZhang, J., Zhao, X., Zhao, Y., Zhang, J., Zhang, Z., Wang, J., Wang, Y., Dai, M., & Han, J. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04592-1 · Cited by 205
Da-ano, R., Masson, I., Lucia, F., Doré, M., Robin, P., Alfieri, J., Rousseau, C., Mervoyer, A., Reinhold, C., Castelli, J., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-66110-w · Cited by 204
The requirements of a specialist breast centre
Biganzoli, L., Cardoso, F., Beishon, M., Cameron, D., Cataliotti, L., Coles, C. E., Delgado Bolton, R. C., Trill, M. D., Erdem, S., Fjell, M., et al. (2020) · The Breast · doi:10.1016/j.breast.2020.02.003 · Cited by 198
Hatt, M., Lee, J. A., Schmidtlein, C. R., Naqa, I. E., Caldwell, C., De Bernardi, E., Lu, W., Das, S., Geets, X., Gregoire, V., et al. (2017) · Medical Physics · doi:10.1002/mp.12124 · Cited by 198
Barrington, S. F., Kirkwood, A. A., Franceschetto, A., Fulham, M. J., Roberts, T. H., Almquist, H., Brun, E., Hjorthaug, K., Viney, Z. N., Pike, L. C., et al. (2016) · Blood · doi:10.1182/blood-2015-11-679407 · Cited by 188
Self-citationHigh total metabolic tumor volume at baseline predicts survival independent of response to therapy
Vercellino, L., Cottereau, A.-S., Casasnovas, O., Tilly, H., Feugier, P., Chartier, L., Fruchart, C., Roulin, L., Oberic, L., Pica, G. M., et al. (2020) · Blood · doi:10.1182/blood.2019003526 · Cited by 186
Casali, M., Lauri, C., Altini, C., Bertagna, F., Cassarino, G., Cistaro, A., Erba, A. P., Ferrari, C., Mainolfi, C. G., Palucci, A., et al. (2021) · Clinical and Translational Imaging · doi:10.1007/s40336-021-00445-w · Cited by 178
“For all the other infective and inflammatory disorders, the same acquisition, reconstruction and post-processing steps described in the EANM procedural guidelines for tumour imaging and for inflammations and infections are recommended [27, 268].”
BackgroundMethodKirienko, M., Cozzi, L., Antunovic, L., Lozza, L., Fogliata, A., Voulaz, E., Rossi, A., Chiti, A., & Sollini, M. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3837-7 · Cited by 179
Self-citationCeriani, L., Martelli, M., Zinzani, P. L., Ferreri, A. J. M., Botto, B., Stelitano, C., Gotti, M., Cabras, M. G., Rigacci, L., Gargantini, L., et al. (2015) · Blood · doi:10.1182/blood-2014-12-616474 · Cited by 178
EANM/EARL FDG-PET/CT accreditation - summary results from the first 200 accredited imaging systems
Kaalep, A., Sera, T., Oyen, W., Krause, B. J., Chiti, A., Liu, Y., & Boellaard, R. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3853-7 · Cited by 174
Self-citationDissaux, G., Visvikis, D., Da-ano, R., Pradier, O., Chajon, E., Barillot, I., Duvergé, L., Masson, I., Abgral, R., Santiago Ribeiro, M.-J., et al. (2020) · Journal of Nuclear Medicine · doi:10.2967/jnumed.119.228106 · Cited by 172
“PET/CT Image Acquisition and Image Analysis PET/CT images were acquired 60 6 5 min after 18F-FDG injection in accordance with the European Association of Nuclear Medicine guidelines (10).”
MethodGuidelines on nuclear medicine imaging in neuroblastoma
Bar-Sever, Z., Biassoni, L., Shulkin, B., Kong, G., Hofman, M. S., Lopci, E., Manea, I., Koziorowski, J., Castellani, R., Boubaker, A., et al. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4070-8 · Cited by 169
Self-citationChallenges and Promises of PET Radiomics
Cook, G. J. R., Azad, G., Owczarczyk, K., Siddique, M., & Goh, V. (2018) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2017.12.268 · Cited by 167
18F-NaF PET/CT: EANM procedure guidelines for bone imaging
Beheshti, M., Mottaghy, F. M., Payche, F., Behrendt, F. F. F., Van den Wyngaert, T., Fogelman, I., Strobel, K., Celli, M., Fanti, S., Giammarile, F., et al. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3138-y · Cited by 167
Self-citationHarmonization strategies for multicenter radiomics investigations
Da-Ano, R., Visvikis, D., & Hatt, M. (2020) · Physics in Medicine & Biology · doi:10.1088/1361-6560/aba798 · Cited by 161
“The study chose one reconstruction setting that is line with the standards provided by EARL (European Association of Nuclear Medicine (EANM) Research Ltd) (Boellaard et al 2015).”
BackgroundMethodFeasibility of state of the art PET/CT systems performance harmonisation
Kaalep, A., Sera, T., Rijnsdorp, S., Yaqub, M., Talsma, A., Lodge, M. A., & Boellaard, R. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-3977-4 · Cited by 160
Self-citationMultimodal Spatial Attention Module for Targeting Multimodal PET-CT Lung Tumor Segmentation
Fu, X., Bi, L., Kumar, A., FULHAM, M. J., & Kim, J. (2021) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2021.3059453 · Cited by 182
“As such, PETCT tumor segmentation still relies upon specialist imaging expertise to discern the relevant information captured by each modality with attendant high costs, and inter- and intra-observer inconsistencies [8, 9].”
BackgroundPérez-García, J. M., Gebhart, G., Ruiz Borrego, M., Stradella, A., Bermejo, B., Schmid, P., Marmé, F., Escrivá-de-Romani, S., Calvo, L., Ribelles, N., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00122-4 · Cited by 159
PET Radiomics in NSCLC: state of the art and a proposal for harmonization of methodology
Sollini, M., Cozzi, L., Antunovic, L., Chiti, A., & Kirienko, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-00426-y · Cited by 158
Self-citationBarrington, S. F., & Meignan, M. (2019) · Journal of Nuclear Medicine · doi:10.2967/jnumed.119.227249 · Cited by 158
“Solutions to deal with uncertainties in technical and biologic factors (41) are included in international guidance (42) and are commonly applied in trials and clinical practice for tumor imaging.”
BackgroundSelf-citationAlbert, N. L., Galldiks, N., Ellingson, B. M., van den Bent, M. J., Chang, S. M., Cicone, F., de Groot, J., Koh, E., Law, I. G., Rhun, É. L., et al. (2024) · The Lancet Oncology · doi:10.1016/s1470-2045(23)00525-9 · Cited by 208
Hodgkin Lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
Hoppe, R. T., Advani, R. H., Ai, W. Z., Ambinder, R. F., Armand, P. A., Bello, C. M., Benitez, C. M., Bierman, P. J., Boughan, K. M., Dabaja, B. S., et al. (2020) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2020.0026 · Cited by 181
Hatt, M., Krizsan, A. K., Rahmim, A., Bradshaw, T., Costa, P. F., Forgács, A., Seifert, R., Zwanenburg, A., Naqa, I. E., Kinahan, P. E., et al. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-022-06001-6 · Cited by 176
Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study
Sollini, M., Morbelli, S. D., Ciccarelli, M., Cecconi, M., Aghemo, A., Morelli, P., Chiola, S., Gelardi, F., & Chiti, A. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05294-3 · Cited by 166
“Table 4 Results of visual analysis in controls [18]FDG uptake location Melanoma patients”
BackgroundMethodSelf-citationIlyas, H., Mikhaeel, N. G., Dunn, J. T., Rahman, F., Møller, H., Smith, D., & Barrington, S. F. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-3953-z · Cited by 150
Self-citationThe Place of FDG PET/CT in Renal Cell Carcinoma: Value and Limitations
Liu, Y. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00201 · Cited by 149
Lopci, E., Toschi, L., Grizzi, F., Rahal, D., Olivari, L., Castino, G. F., Marchetti, S., Cortese, N., Qehajaj, D., Pistillo, D., et al. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3425-2 · Cited by 154
Self-citationDelfau‐Larue, M., Gucht, A. V. D., Dupuis, J., Jaïs, J., Nel, I., Beldi‐Ferchiou, A., Hamdane, S., Benmaad, I., Labouré, G., Verret, B., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2017015164 · Cited by 161
Nanni, C., Versari, A., Chauvie, S., Bertone, E., Bianchi, A., Rensi, M., Bellò, M., Gallamini, A., Patriarca, F. F., Gay, F., et al. (2017) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3909-8 · Cited by 146
Kirienko, M., Cozzi, L., Rossi, A., Voulaz, E., Antunovic, L., Fogliata, A., Chiti, A., & Sollini, M. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-3987-2 · Cited by 148
Self-citationRecommendations on nuclear and multimodality imaging in IE and CIED infections
Erba, P. A., Lancellotti, P., Vilacosta, I., Gaemperli, O., Rouzet, F., Hacker, M., Signore, A., Slart, R. H. J. A., & Habib, G. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4025-0 · Cited by 160
Antunovic, L., Sanctis, R. D., Cozzi, L., Kirienko, M., Sagona, A., Torrisi, R., Tinterri, C., Santoro, A., Chiti, A., Zelić, R., et al. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04313-8 · Cited by 150
Self-citationCysouw, M. C. F., Jansen, B. H. E., van de Brug, T., Oprea‐Lager, D. E., Pfaehler, E. A. G., de Vries, B. M., van Moorselaar, R. J. A., Hoekstra, O. S., Vis, A. N., & Boellaard, R. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-04971-z · Cited by 156
Self-citationZamagni, E., Nanni, C., Dozza, L., Carlier, T., Bailly, C., Tacchetti, P., Versari, A., Chauvie, S., Gallamini, A., Gamberi, B., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.00386 · Cited by 175
Zamagni, E., Nanni, C., Gay, F., Pezzi, A., Patriarca, F. F., Bellò, M., Rambaldi, I., Tacchetti, P., Hillengaß, J., Gamberi, B., et al. (2015) · Leukemia · doi:10.1038/leu.2015.291 · Cited by 146
EANM practice guideline for PET/CT imaging in medullary thyroid carcinoma
Giovanella, L., Treglia, G., Iakovou, I. P., Mihailovic, J. M., Verburg, F. A., & Luster, M. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04458-6 · Cited by 142
FDG ‐ PET / CT in the management of lymphomas: current status and future directions
El‐Galaly, T. C., Villa, D. R., Gormsen, L. C., Bæch, J., Lo, A., & Cheah, C. Y. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12813 · Cited by 155
deSouza, N. M., Liu, Y., Chiti, A., Oprea‐Lager, D. E., Gebhart, G., BEERS, B. E. V., Herrmann, K., & Lecouvet, F. E. (2018) · European Journal of Cancer · doi:10.1016/j.ejca.2017.12.012 · Cited by 140
Self-citationEertink, J. J., van de Brug, T., Wiegers, S. E., Zwezerijnen, G. J. C., Pfaehler, E. A. G., Lugtenburg, P. J., van der Holt, B., de Vet, H. C. W., Hoekstra, O. S., Boellaard, R., et al. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05480-3 · Cited by 151
Self-citationSNMMI Procedure Standard/EANM Practice Guideline for SSTR PET: Imaging Neuroendocrine Tumors
Hope, T. A., Allen-Auerbach, M., Bodei, L., Calais, J., Dahlbom, M., Dunnwald, L. K., Graham, M. M., Jacene, H. A., Heath, C. L., Mittra, E. S., et al. (2023) · Journal of Nuclear Medicine · doi:10.2967/jnumed.122.264860 · Cited by 144
“0 (3): PET/CT: An integrated or multimodality PET/CT system is a physical combination of PET and CT that allows sequential acquisition of PET and CT portions.”
BackgroundSelf-citationNielsen, B. D., Hansen, I. T., Kramer, S., Haraldsen, A., Hjorthaug, K., Bogsrud, T. V., Ejlersen, J. A., Stolle, L. B., Keller, K. K., Therkildsen, P., et al. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4106-0 · Cited by 141
Recent advances of PET imaging in clinical radiation oncology
Unterrainer, M., Eze, C., Ilhan, H., Marschner, S. N., Roengvoraphoj, O., Schmidt-Hegemann, N.-S., Walter, F., Kunz, W. G., af Rosenschöld, P. M., Jeraj, R., et al. (2020) · Radiation Oncology · doi:10.1186/s13014-020-01519-1 · Cited by 159
Guidelines for the use of imaging in the management of patients with myeloma
Chantry, A., Kazmi, M. A., Barrington, S. F., Goh, V., Mulholland, N. J. R., Streetly, M. J., Lai, M., Pratt, G., & the British Society for Haematology Guidelines (2017) · British Journal of Haematology · doi:10.1111/bjh.14827 · Cited by 135
Self-citationSeifert, R., Herrmann, K., Kleesiek, J., Schäfers, M. A., Shah, V. P., Xu, Z., Chabin, G., Grbić, S., Spottiswoode, B. S., & Rahbar, K. (2020) · Journal of Nuclear Medicine · doi:10.2967/jnumed.120.242057 · Cited by 139
Vasculitis changes in COVID-19 survivors with persistent symptoms: an [18F]FDG-PET/CT study
Sollini, M., Ciccarelli, M., Cecconi, M., Aghemo, A., Morelli, P., Gelardi, F., & Chiti, A. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-05084-3 · Cited by 130
Self-citationAndritsch, E., Beishon, M., Bielack, S., Bonvalot, S., Casali, P., Crul, M., Delgado-Bolton, R., Donati, D. M., Douis, H., Haas, R., et al. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2016.12.002 · Cited by 128
“…for ensuring the high quality of PET/CT scanners is provided by the European Association of Nuclear Medicine (EANM) through EARL accreditation (Boellaard et al., 2015) • For bone sarcomas and other sarcomas in children, adolescents and young adults, nuclear medicine physicians need sarcoma…”
MethodTan, H., Sui, X., Yin, H., Yu, H., Gu, Y., Chen, S., Hu, P., Mao, W., & Shi, H. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-05091-4 · Cited by 128
Etidronate for Prevention of Ectopic Mineralization in Patients With Pseudoxanthoma Elasticum
Kranenburg, G., de Jong, P. A., Bartstra, J. W., Lagerweij, S. J., Lam, M. G. E. H., Norel, J. O., Risseeuw, S., van Leeuwen, R., Imhof, S. M., Verhaar, H. J. J., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.12.062 · Cited by 133
“Best corrected visual acuity worst eye, ETDRS letters 26 (5-79) 26 (10-79)”
BackgroundMethodPang, Y., Zhao, L., Meng, T., Xu, W., Lin, Q., Wu, H., Zhang, J., Chen, X. S., Sun, L., & Chen, H. (2022) · Journal of Nuclear Medicine · doi:10.2967/jnumed.122.264544 · Cited by 126
“The PET/CT imaging protocols for (18)F-FDG and (68)Ga-FAPI-46 were the same as those for (68)Ga-FAP-2286, except that 6 h of fasting were required before the (18)F-FDG PET/CT scan (the supplemental materials provide details) (18).”
MethodSNMMI Procedure Standard/EANM Practice Guideline on Pediatric18F-FDG PET/CT for Oncology 1.0
Vali, R., Alessio, A. M., Balza, R., Borgwardt, L., Bar‐Sever, Z., Czachowski, M. R., Jehanno, N., Kurch, L., Pandit-Taskar, N. D., Parisi, M. T., et al. (2020) · Journal of Nuclear Medicine · doi:10.2967/jnumed.120.254110 · Cited by 141
Zhang, Y.-Q., Hu, P.-C., Wu, R.-Z., Gu, Y.-S., Chen, S.-G., Yu, H.-J., Wang, X.-Q., Song, J., & Shi, H.-C. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-04823-w · Cited by 123
Sher, A., Lacoeuille, F., Fosse, P., Vervueren, L., Cahouet-Vannier, A., Dabli, D., Bouchet, F., & Couturier, O. (2016) · EJNMMI Research · doi:10.1186/s13550-016-0177-8 · Cited by 111
“A threshold of 41 % was chosen following the EANM guidelines [10] and because the most common thresholding value chosen in the clinical setting is 40–43 % of the SUVmax.”
MethodJiang, M., Sun, D., Guo, Y., Guo, Y., Xiao, J., Wang, L., & Yao, X. (2019) · Academic Radiology · doi:10.1016/j.acra.2019.04.016 · Cited by 130
Dercle, L., Seban, R., Lazarovici, J., Schwartz, L. H., Houot, R., Ammari, S., Danu, A., Edeline, V., Marabelle, A., Ribrag, V., et al. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.193011 · Cited by 123
“18F-FDG PET and CT Scan Acquisitions 18F-FDG PET/CT images were acquired and reconstructed according to guidelines (25) using a Discovery 690 (GE Healthcare) with an activity of 3–4 MBq/kg of 18F-FDG, a 2-min-per-bed acquisition time, and a 90-min delay after 18F-FDG injection.”
MethodSlart, R. H. J. A., Glaudemans, A. W. J. M., Gheysens, O. S., Lubberink, M., Kero, T., Dweck, M. R., Habib, G., Gaemperli, O., Saraste, A., Gimelli, A., et al. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-05066-5 · Cited by 123
“We acknowledge the contribution of previous guidelines onwhich the present are based (1, 8, 13, 14).”
BackgroundMethodInfluentialCalais, J., Kishan, A. U., Cao, M., Fendler, W. P., Eiber, M., Herrmann, K., Ceci, F., Reiter, R. E., Rettig, M. B., Hegde, J. V., et al. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.209387 · Cited by 129
“First, a volume of interest containing the whole prostate and excluding bladder activity was placed on the PET images to automatically generate the contours using a threshold-based segmentation method with a fixed cutoff of 40% of SUVmax (31,32).”
MethodPfaehler, E., Beukinga, R. J., de Jong, J. R., Slart, R. H. J. A., Slump, C. H., Dierckx, R. A. J. O., & Boellaard, R. (2019) · Medical Physics · doi:10.1002/mp.13322 · Cited by 116
“Images were smoothed with Gaussian filters of 0, 2, 4, 6, and 8 mm full width at half maximum (FWHM) and were converted to SUV, so that the mean phantom background SUV was equal to 1.(20)”
MethodSelf-citationRadiomics: Data Are Also Images
Hatt, M., Rest, C. C. L., Tixier, F., Badic, B., Schick, U., & Visvikis, D. (2019) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.220582 · Cited by 132
“First, standardizing PET/CT acquisition and reconstruction protocol settings is an important aspect of multicenter data collection, with guidelines already available for PET/CT imaging (38,39).”
MethodMahmood, M., Kendi, A. T., Farid, S., Ajmal, S., Johnson, G. B., Baddour, L. M., Chareonthaitawee, P., Friedman, P. A., & Sohail, M. R. (2017) · Journal of Nuclear Cardiology · doi:10.1007/s12350-017-1063-0 · Cited by 123
“These preparatory protocols often involve dietary restrictions, activity modification, and blood glucose level management.(27,28) Use of a low carbohydrate, high fat diet in addition to Figure 3.”
Background
Metadata
- Authors
- Boellaard, R., Delgado-Bolton, R., Oyen, W. J. G., Giammarile, F., Tatsch, K., Eschner, W., Verzijlbergen, F. J., Barrington, S. F., Pike, L. C., Weber, W. A., Stroobants, S., Delbeke, D., Donohoe, K. J., Holbrook, S., Graham, M. M., Testanera, G., Hoekstra, O. S., Zijlstra, J., Visser, E., Hoekstra, C. J., Pruim, J., Willemsen, A., Arends, B., Kotzerke, J., Bockisch, A., Beyer, T., Chiti, A., & Krause, B. J.
- Affiliations
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- Radboud University Medical Center (NL)
- Hospices Civils de Lyon (FR)
- Städtisches Klinikum Karlsruhe (DE)
- University of Cologne (DE)
- Erasmus MC (NL)
- St Thomas' Hospital (GB)
- Memorial Sloan Kettering Cancer Center (US)
- Antwerp University Hospital (BE)
- Vanderbilt University Medical Center (US)
- Beth Israel Deaconess Medical Center (US)
- Insilico Medicine (United States) (US)
- University of Iowa (US)
- Humanitas University (IT)
- Jeroen Bosch Ziekenhuis (NL)
- University Medical Center Groningen (NL)
- Catharina Ziekenhuis (NL)
- University Hospital Carl Gustav Carus (DE)
- Essen University Hospital (DE)
- Medical University of Vienna (AT)
- Universitätsmedizin Rostock (DE)
- Corresponding author
- Boellaard, Ronald
- ORCID
- Venue
- European Journal of Nuclear Medicine and Molecular Imaging
- Published
- 2014-12-02
- Volume
- 42
- Issue
- 2
- Pages
- 328-354
- ISSN
- 1619-7070 (ISSN-L)
- 1619-7089
- PMC
- PMC4315529
- OpenAlex
- W2088783247
- Cited by
- 3,303
- References
- 109
- Citations by year
- 2026: 306 · 2025: 341 · 2024: 388 · 2023: 333 · 2022: 405 · 2021: 408 · 2020: 296 · 2019: 258 · 2018: 230 · 2017: 159 · 2016: 115 · 2015: 54
- FWCI
- 85.55
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- European Journal of Nuclear Medicine and Molecular Imaging (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Kölner Universitäts PublikationsServer (Universität zu Köln) (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- Pure Amsterdam UMC (acceptedVersion, other-oa)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Universitätsbibliographie, Universität Duisburg-Essen (submittedVersion)
- Research Portal (King's College London) (submittedVersion, other-oa)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by)
- Radboud Repository (Radboud University) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Topics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiomics and Machine Learning in Medical Imaging
- Keywords
- FDG PET/CT, tumor imaging, standardized uptake value, quantitative imaging, quality control, quality assurance, repeatability, reproducibility, imaging biomarkers, tumor response assessment, tumor staging, cancer diagnosis, cancer prognosis, EANM guidelines
- MeSH terms
- Humans, Neoplasms, Tomography, X-Ray Computed, Radiopharmaceuticals, Fluorodeoxyglucose F18, Positron-Emission Tomography, Multimodal Imaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.